Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Net Cash Flow: 2020-2025

Historic Net Cash Flow for Molecular Partners Ag (MOLN) over the last 5 years, with Sep 2025 value amounting to -$24.0 million.

  • Molecular Partners Ag's Net Cash Flow fell 906.74% to -$24.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.7 million, marking a year-over-year increase of 67.03%. This contributed to the annual value of -$4.9 million for FY2024, which is 71.55% up from last year.
  • Per Molecular Partners Ag's latest filing, its Net Cash Flow stood at -$24.0 million for Q3 2025, which was down 203.48% from $23.2 million recorded in Q2 2025.
  • Over the past 5 years, Molecular Partners Ag's Net Cash Flow peaked at $42.5 million during Q2 2022, and registered a low of -$67.8 million during Q4 2021.
  • For the 3-year period, Molecular Partners Ag's Net Cash Flow averaged around -$2.1 million, with its median value being -$14,564 (2023).
  • Over the last 5 years, Molecular Partners Ag's Net Cash Flow had its largest YoY gain of 6,414.49% in 2025, and its largest YoY loss of 906.74% in 2025.
  • Over the past 5 years, Molecular Partners Ag's Net Cash Flow (Quarterly) stood at -$67.8 million in 2021, then soared by 124.30% to $16.5 million in 2022, then slumped by 206.12% to -$17.5 million in 2023, then skyrocketed by 71.76% to -$4.9 million in 2024, then tumbled by 906.74% to -$24.0 million in 2025.
  • Its Net Cash Flow was -$24.0 million in Q3 2025, compared to $23.2 million in Q2 2025 and $19,554 in Q1 2025.